Inventor · disambiguated record
Shuhui Chen
Also filed as: CHEN SHUHUI
221 granted patents·116 pending applications·228 citations·filing 2012–2025
99Inventor score
Files withMEDSHINE DISCOVERY INC99CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD47GUANGDONG RAYNOVENT BIOTECH CO LTD15D3 BIO WUXI CO LTD9SHANDONG DANHONG PHARMACEUTICAL CO LTD8
Top patents by PatentIndex Score
337 records- 0194US12458647B2Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Granted Nov 4, 2025·1 cites·30 claims
- 0293US11725009B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2021·Granted Aug 15, 2023·2 cites·17 claims
- 0391US9969719B2Substituted 2-hydrogen-pyrazole derivative serving as anticancer drugCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted May 15, 2018·9 cites·15 claims
- 0491US9938301B2Dihydropyrimido fused ring derivative as HBV inhibitorQILU PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·27 cites·18 claims
- 0590US11535613B2Crystal form and salt form of pyridoimidazole compound and preparation method thereforGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2019·Granted Dec 27, 2022·6 cites·25 claims
- 0690US9938292B2Quinoline derivatives as SMO inhibitorsGUANGDONG ZHONGSHENG PHARMACEUTICAL CO LTD·Filed 2015·Granted Apr 10, 2018·19 cites·20 claims
- 0789US11136319B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Oct 5, 2021·4 cites·19 claims
- 0888US12012404B2Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2023·Granted Jun 18, 2024·1 cites·30 claims
- 0988US10745389B2HDAC6 selective inhibitors, preparation method therefor, and application thereofCSTONE PHARMACEUTICALS (SUZHOU) CO LTD·Filed 2018·Granted Aug 18, 2020·6 cites·17 claims
- 1087US11542272B2Five-membered heteroaryl-fused imidazole compound and application thereofHANGZHOU SCIWIND BIOSCIENCES CO LTD·Filed 2022·Granted Jan 3, 2023·2 cites·19 claims
- 1187US10519133B2Vinyl compounds as FGFR and VEGFR inhibitorsMEDSHINE DISCOVERY INC·Filed 2016·Granted Dec 31, 2019·4 cites·16 claims
- 1286US11932617B2Compound for use in retinal diseasesZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 19, 2024·3 cites·6 claims
- 1386US11053260B2Tri-cycle compound and applications thereofFUJIAN COSUNTER PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 6, 2021·4 cites·18 claims
- 1486US11001563B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2019·Granted May 11, 2021·3 cites·19 claims
- 1585US10875888B2Steroid derivative FXR agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Dec 29, 2020·3 cites·20 claims
- 1685US10633351B2Halogenated compound and axially chiral isomer thereofMEDSHINE DISCOVERY INC·Filed 2017·Granted Apr 28, 2020·2 cites·20 claims
- 1784US11505532B2SSAO inhibitorSHANDONG DANHONG PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 22, 2022·1 cites·9 claims
- 1884US11433053B2LSD1 inhibitor and preparation method and application thereofCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Sep 6, 2022·3 cites·30 claims
- 1983US11753377B2Crystal form of 2-methyl-2-propanol and amino-substituted aryl compoundZHUHAI UNITED LABORATORIES CO LTD·Filed 2021·Granted Sep 12, 2023·1 cites·14 claims
- 2083US11459323B2Monocyclic β-lactam compound for treating bacterial infectionMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 4, 2022·3 cites·20 claims
- 2183US11286248B2Pyrazine-2(1H)-ketone compound acting as FGFR inhibitorZHANGZHOU PIEN TZE HUANG PHARM·Filed 2019·Granted Mar 29, 2022·3 cites·18 claims
- 2283US11091460B2Syk inhibitor and use method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Aug 17, 2021·3 cites·20 claims
- 2383US9255111B2Parasiticidal dihydroisoxazole compoundsLILLY CO ELI·Filed 2014·Granted Feb 9, 2016·5 cites·20 claims
- 2482US12378253B2Pyrrolopyrimidine compound as BTK inhibitor and use thereofZHEJIANG LONGCHARM BIO TECH PHARMA CO LTD·Filed 2020·Granted Aug 5, 2025·2 cites·11 claims
- 2582US12319692B2Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·17 claims
- 2682US11459337B2Isothiazolo[5,4-D]pyrimidine compound as IRAK4 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Oct 4, 2022·2 cites·20 claims
- 2782US10100047B2Piperidine derivatives as orexin receptor antagonistSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 16, 2018·5 cites·10 claims
- 2881US12378241B2Pyridine derivative as FGFR and VEGFR dual inhibitorsCGENETECH SUZHOU CHINA CO LTD·Filed 2020·Granted Aug 5, 2025·1 cites·20 claims
- 2981US11434232B2ATR inhibitor and application thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Sep 6, 2022·2 cites·19 claims
- 3081US11339147B2Lactam compound as FXR receptor agonistCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted May 24, 2022·2 cites·15 claims
- 3181US11332465B2Diarylthiohydantoin compound as androgen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 17, 2022·3 cites·20 claims
- 3281US2024287117A1Deuterated nucleoside compounds and use thereofMEDSHINE DISCOVERY INC·Filed 2024·Application pending·0 cites
- 3381US2024262837A1Deuterated nucleoside compounds and use thereofMEDSHINE DISCOVERY INC·Filed 2024·Application pending·0 cites
- 3480US12054482B2TLR8 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 6, 2024·1 cites·11 claims
- 3580US11919896B2[1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereofZHUHAI UNITED LABORATORIES CO LTD·Filed 2019·Granted Mar 5, 2024·2 cites·19 claims
- 3680US11613545B2Macrocyclic compound serving as Wee1 inhibitor and applications thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2018·Granted Mar 28, 2023·2 cites·20 claims
- 3780US11453667B2Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted Sep 27, 2022·2 cites·19 claims
- 3880US11136315B2CXCR2 antagonistMEDSHINE DISCOVERY INC·Filed 2019·Granted Oct 5, 2021·2 cites·18 claims
- 3979US11623923B2Uracil compound as c-MET/AXL inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Apr 11, 2023·2 cites·23 claims
- 4079US11464780B2Pyrazolopyrimidine derivative and use thereofSimcere pharmaceutical co ltd·Filed 2019·Granted Oct 11, 2022·2 cites·19 claims
- 4179US11358950B2SMAC mimetics used as IAP inhibitors and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jun 14, 2022·2 cites·19 claims
- 4279US11345678B2Benzopyrazole compound used as RHO kinase inhibitorMEDSHINE DISCOVERY INC·Filed 2019·Granted May 31, 2022·2 cites·19 claims
- 4379US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
- 4479US10526320B2Pyrrolidine derivatives as PPAR agonistsGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Jan 7, 2020·2 cites·20 claims
- 4579US10278973B2Hydroxyl purine compounds and use thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2016·Granted May 7, 2019·2 cites·10 claims
- 4679US9856256B2Pyridino[1,2-A]pyrimidone analogue used as P13K inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted Jan 2, 2018·3 cites·16 claims
- 4779US2025250275A1Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 4878US11905276B2Bicyclic compound that acts as CRBN protein regulatorMEDSHINE DISCOVERY INC·Filed 2020·Granted Feb 20, 2024·1 cites·11 claims
- 4978US11352331B2Crystal and salt of 4-(naphthalen-1-yl)-4H-1,2,4-triazole compound and preparation method thereforMEDSHINE DISCOVERY INC·Filed 2018·Granted Jun 7, 2022·1 cites·7 claims
- 5078US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
Showing the top 50 of 337 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shuhui Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →